PARTNERS

Start with the outcome. Build the evidence and deployment path together.

NeuTigers works with device manufacturers, life-sciences companies, care organizations and clinical researchers to translate Edge-AI science into defined partner programs.

Find your partnership pathway →

ENGAGEMENT MODELS

Flexible structures. Explicit decision gates.

The right structure depends on intended use, data access, evidence maturity, device constraints and geography.

Co-development

Technology licensing

Device integration

Geographic commercialization

END-TO-END PARTNER OFFERING

Partner Offering — fully integrated and optimized product development.

From project internal kick-off to partner deployment: study design, planning, execution and algorithm DevOps in one gated program.

Project Internal Kick-Off→

Study’s Design

Exploratory-Field Study

Test the apps
Validate the data flow
Adjust if needed the study design and amend associated protocol and regulatory documents

Study Design

Identify the right KOLs/PIs
Establish the specific use cases and objectives of the study
Consolidate the prospective study protocol
Obtain regulatory approval (IRB)

Study’s Planning

Study Clinic PI’s Kick-off

Present the study to the medical team
Assign the tasks and responsibilities
Validate the feasibility of the study (human resources, devices, logistics, etc.)

Study Planning

Medical team training
Schedule of participants’ enrollment
Establish the study timeline

Study’s Execution

Data Collection and Processing

Gather, process and control quality (raw data and labeling)
Augment data using synthetic data and data labeling solutions

Study Oversight

Feedback of the medical team
Integration of the trial tasks to their daily activity
Provide adjustment if necessary

Signal Validation

Conduct additional analyses to establish the signal is accurate, reliable and reproduceable

Algorithm DevOps

Algorithm Development

Optimize on-device deep neural network (DNN) algorithm leveraging proprietary edge technology

Disease/ Wellness Predictive Algorithms

Partner’s Deployment

Partner with client to deploy solution across all required platforms and divisions
Continuously support client to update and further optimize AI algorithms as needed or required

INDICATIVE PROCESS

Discovery

Feasibility

Data & clinical plan

Model development

Validation

Deployment

Each stage has defined inputs, decision criteria, owners and evidence requirements. Scope and timing are agreed for each engagement.

CHANNELS

One platform. Five partner channels.

SweetDeep® brings clinically validated metabolic intelligence to every part of the healthcare value chain — clinically validated, privacy by design, Edge-AI enabled and globally scalable.

Smartwatch and fitness band showing metabolic score

WEARABLE OEMs

Integrate metabolic intelligence into watches

Differentiate devices with advanced health capabilities
Increase user engagement and device stickiness
Unlock new services and revenue streams

Partner as a wearable OEM →

Metabolic response chart for treatment versus placebo

PHARMACEUTICALS

Patient identification, trials & digital companions

Enrich trials with the right high-risk populations
Improve trial efficiency and reduce costs
Engage and monitor patients with digital companion tools

Start a pharma discussion →

Connected medical device and companion app with metabolic score

MEDICAL DEVICES

CGM integration & risk stratification

Integrate with CGM and other medical devices
Risk stratification for better clinical decisions
Enhance device value and clinical adoption

Integrate with your device →

Metabolic insights dashboards across desktop, tablet and phone

HEALTHCARE PLATFORMS

Remote risk screening at scale

Population-wide remote risk screening
Early identification and care pathway activation
Improve outcomes and reduce total cost of care

Deploy on your platform →

Employee population with population metabolic score and risk reduction

PAYERS / EMPLOYERS

Population screening & lifestyle intervention

Identify at-risk individuals early in the population
Drive targeted lifestyle interventions
Reduce claims, lower costs and improve productivity

Screen your population →

RESEARCH INSTITUTIONS

Co-develop and validate digital biomarkers.

For research and clinical institutions targeting high-unmet-need conditions.

Useful starting inputs: Cohort, protocol, data access and scientific question.
Typical engagement: Research collaboration · sponsored study
Foundation: Decentralized study know-how, IRB-approved data collection and the KB-PCMHD cardiometabolic knowledge base.

Start a research collaboration →

TRACTION